@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix chebi: . @prefix sdis: . @prefix do: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 rdf:object sdis:tumor%20growth; rdf:predicate belv:decreases; rdf:subject chebi:7887; a rdf:Statement . sub:_2 occursIn: do:3908, species:10090; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject schem:ADAM10%20inhibitor; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:paclitaxel) -| path(SDIS:\"tumor growth\")", "a(SCHEM:\"ADAM10 inhibitor\") -> (a(CHEBI:paclitaxel) -| path(SDIS:\"tumor growth\"))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "20131211" . sub:_3 prov:value "ADAM10 and ADAM17 inhibitor in cell and animal models. This inhibitor also acts synergistically with the chemotherapeutic agent paclitaxel to reduce tumour volume in a mouse model of non-small-cell lung cancer103."; prov:wasQuotedFrom pubmed:19005493 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:19005493; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:27.963+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }